Stem Cell Therapy Market 2025–2029: Tracking 12.1% CAGR Toward $14.6 Billion in Revenue

Uncover key drivers, emerging technologies, and competitive movements shaping the stem cell therapy market from 2025–2034 with trusted insights from The Business Research Company

How Will The Stem Cell Therapy Market Size Evolve Between Now And 2029?

The stem cell therapy market size has seen rapid expansion in recent years. It is projected to increase from $7.86 billion in 2024 to $9.26 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 17.7%. The growth observed in the historic period can be ascribed to the rising prevalence of chronic diseases, an increase in funding from governments and private organizations, rapid development in emerging markets, a boost in investments toward cell and gene therapies, a surge in healthcare expenditure, and an expansion in pharmaceutical r&d expenditure.

The stem cell therapy market is poised for significant expansion in the coming years, with its value projected to reach $14.6 billion by 2029, achieving a compound annual growth rate (CAGR) of 12.1%. This growth during the forecast period is attributed to factors like increased government support, a rapidly growing aging population, rising research and development investments, and higher healthcare expenditure. Key trends for this period include a focus on closely monitoring progress in mesenchymal stem cell therapy to leverage innovations, the need for market players to collaborate with and acquire other companies to drive product advancement and revenue, the suggestion for companies to invest in developing iPSC-derived NK cells for patient treatment, a recommendation for firms in the stem cell therapy market to concentrate on cancer therapies to gain a competitive advantage over somatic cell competitors, and the adoption of artificial intelligence to enhance product quality, safety, and manufacturing productivity.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&type=smp

Which Key Drivers Are Powering Growth In The Stem Cell Therapy Market?

The increasing occurrence of chronic diseases has fueled the expansion of the stem cell therapy market. Lifestyle factors such as prolonged working hours, reduced physical activity, and poor eating and drinking habits contribute to the widespread nature of chronic diseases among individuals, consequently boosting the demand for stem cell therapy. As per a United Nations article, by 2030, the percentage of worldwide deaths attributed to chronic diseases is predicted to climb to 70% of total deaths. The overall impact of chronic diseases globally is foreseen to reach about 60%. This upward trend in chronic disease prevalence is expected to propel the stem cell therapy market growth.

How Is The Global Stem Cell Therapy Market Structured By Key Segments?

The stem cell therapy market covered in this report is segmented –

1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy

2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells

3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others

4) By End-Users: Hospitals And Clinics, Research Centers, Others.

Subsegments:

1) By Allogeneic Stem Cell Therapy: Derived From Donors (Related Or Unrelated), Used For Various Conditions, Including Blood Disorders And Certain Cancers, Examples Include Umbilical Cord Blood Stem Cells And Peripheral Blood Stem Cells

2) By Autologous Stem Cell Therapy: Derived From The Patient’s Own Cells, Used For Conditions Such As Orthopedic Injuries, Cardiac Diseases, And Certain Cancers, Involves The Harvesting Of Stem Cells From Tissues Like Bone Marrow Or Adipose Tissue

What Future-Focused Trends Are Anticipated In The Stem Cell Therapy Market?

Companies within the stem cell therapy market are increasingly allocating resources towards strategic alliances. A strategic partnership involves a reciprocal agreement between two firms that do not directly compete. For example, in May 2022, SQZ Biotechnologies, a US-based biotechnology company, collaborated with STEMCELL Technologies Inc., a Canada-based biotechnology company, to create and commercialize a research-use-only (RUO) microfluidic intracellular delivery system. This system, built on SQZ’s Cell Squeeze technology, aims to equip the life sciences community with superior cell engineering capabilities for preclinical research. Both companies plan to release important findings concerning the RUO system’s potential for efficient cargo delivery to primary immune cell types and to highlight progress in cell engineering using mRNA and CRISPR/Cas9 in hematopoietic stem cells.

Which Companies Hold A Competitive Edge In The Stem Cell Therapy Market?

Major companies operating in the stem cell therapy market include Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., MEDIPOST Co., Ltd., Astellas Pharma Inc., Catalent, Inc., Pharmicell Co., Ltd., JCR Pharmaceuticals Co., Ltd., Stemedica Cell Technologies, Inc., Pluristem Technologies Ltd, Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd, Cordlife India Pvt. Ltd, Lifecell International Pvt. Ltd, Stemcyte India Therapeutics Private Limited, Stempeutics Research Private Limited, Anterogen Co., Ltd, Tonghua Dongbao Pharmaceutical Co, China Biologic Products Holdings Inc, Astrazenaca, Ablbio, Henlius, China Regenerative Medicine International, Innovent Biologics, Bio-Thera, Hisun Pharma, 3sbio, Beijing Shuanglu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals, Cellerix, Cellgenix, Nsgene, Tigenix, Renuron Group, Smart Cells And Genenta Science, Amsterdam Molecular Therapeutics (Amt), Ark Therapeutics, Arthrogen Bv, Diamyd Medical Ab, Oxford Biomedica, Transgene, Mabion, Pure Biologics, Oncoarendi Therapeutics, Celon Pharma, Becton Dickinson And Company, Osiris Therapeutics, Capricortherapeutics, Cellular Dynamics Discgenics, Takeda Pharmaceuticals, Kolon Tissue Gene, Athersys, Cyro-Cell International, Geron Corporation, Mesoblast Ltd, Astrom Biosciences Inc, Invitrogen, Cytori Therapeutics Inc, Nuvasive Inc, Bristol-Myers Squibb Aldagen Inc, Caladrius Biosciences Inc, Biogen Sa, Daiichi Sankyo Co. Ltd, Gamida Cell Ltd, Gilead Sciences, Inc., Novartis Ag, Pfizer, Sanofi S.A.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Which Region Is Expected To Lead The Stem Cell Therapy Market In The Next Few Years?

North America was the largest region in the stem cell therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=3399&type=smp

Browse Through More Reports Similar to the Global Stem Cell Therapy Market 2025, By The Business Research Company

3D Cell Culture Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

Cell Culture Consumables And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

Transplant Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795